Annual Total Long Term Liabilities
$5.52 M
+$3.02 M+120.69%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual total long term liabilities is $5.52 million, with the most recent change of +$3.02 million (+120.69%) on December 31, 2023.
- During the last 3 years, HEPA annual total long term liabilities has risen by +$2.06 million (+59.50%).
- HEPA annual total long term liabilities is now -17.63% below its all-time high of $6.71 million, reached on June 30, 2016.
Performance
HEPA Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.41 M
-$66.90 K-4.54%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly total long term liabilities is $1.41 million, with the most recent change of -$66.90 thousand (-4.54%) on September 30, 2024.
- Over the past year, HEPA quarterly long term liabilities has dropped by -$1.04 million (-42.43%).
- HEPA quarterly long term liabilities is now -85.55% below its all-time high of $9.73 million, reached on March 31, 2014.
Performance
HEPA Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
HEPA Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +120.7% | -42.4% |
| 3 y3 years | +59.5% | -40.2% |
| 5 y5 years | +64.2% | -40.2% |
HEPA Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.9% | -76.2% | at low |
| 5 y | 5-year | at high | +134.9% | -76.2% | at low |
| alltime | all time | -17.6% | -100.0% | -85.5% | -100.0% |
Hepion Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.41 M(-4.5%) |
| Jun 2024 | - | $1.47 M(-75.0%) |
| Mar 2024 | - | $5.89 M(+6.7%) |
| Dec 2023 | $5.52 M(+120.7%) | $5.52 M(+126.2%) |
| Sep 2023 | - | $2.44 M(-0.5%) |
| Jun 2023 | - | $2.46 M(-3.5%) |
| Mar 2023 | - | $2.54 M(+1.6%) |
| Dec 2022 | $2.50 M(+6.5%) | $2.50 M(-15.1%) |
| Sep 2022 | - | $2.95 M(+2.8%) |
| Jun 2022 | - | $2.87 M(-3.0%) |
| Mar 2022 | - | $2.96 M(+25.9%) |
| Dec 2021 | $2.35 M(-32.1%) | $2.35 M(+25.3%) |
| Sep 2021 | - | $1.88 M(-2.8%) |
| Jun 2021 | - | $1.93 M(-41.8%) |
| Mar 2021 | - | $3.31 M(-4.3%) |
| Dec 2020 | $3.46 M(+2.3%) | $3.46 M(-2.0%) |
| Sep 2020 | - | $3.53 M(+10.9%) |
| Jun 2020 | - | $3.19 M(+7.5%) |
| Mar 2020 | - | $2.97 M(-12.4%) |
| Dec 2019 | $3.39 M(+0.6%) | $3.39 M(+1.3%) |
| Sep 2019 | - | $3.34 M(-4.8%) |
| Jun 2019 | - | $3.51 M(-7.6%) |
| Mar 2019 | - | $3.80 M(+13.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $3.36 M(-32.0%) | $3.36 M(-17.4%) |
| Sep 2018 | - | $4.07 M(+9.3%) |
| Jun 2018 | - | $3.73 M(-1.4%) |
| Mar 2018 | - | $3.78 M(-40.1%) |
| Dec 2017 | $4.95 M(-22.5%) | - |
| Sep 2017 | - | $6.32 M(-1.0%) |
| Jun 2017 | $6.38 M(-4.8%) | $6.38 M(-34.0%) |
| Mar 2017 | - | $9.67 M(+38.8%) |
| Dec 2016 | - | $6.97 M(+4.7%) |
| Sep 2016 | - | $6.65 M(-0.8%) |
| Jun 2016 | $6.71 M(>+9900.0%) | $6.71 M(+475.2%) |
| Mar 2016 | - | $1.17 M(-38.7%) |
| Dec 2015 | - | $1.90 M(>+9900.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | - | $0.00(0.0%) |
| Sep 2014 | - | $0.00(-100.0%) |
| Jun 2014 | $4.48 M(>+9900.0%) | $4.48 M(-54.0%) |
| Mar 2014 | - | $9.73 M(>+9900.0%) |
| Dec 2013 | - | $0.00(0.0%) |
| Sep 2013 | - | $0.00 |
| Jun 2013 | $0.00 | - |
FAQ
- What is Hepion Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual total long term liabilities year-on-year change?
- What is Hepion Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly long term liabilities year-on-year change?
What is Hepion Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of HEPA is $5.52 M
What is the all time high annual total long term liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual total long term liabilities is $6.71 M
What is Hepion Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, HEPA annual total long term liabilities has changed by +$3.02 M (+120.69%)
What is Hepion Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of HEPA is $1.41 M
What is the all time high quarterly long term liabilities for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly total long term liabilities is $9.73 M
What is Hepion Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, HEPA quarterly total long term liabilities has changed by -$1.04 M (-42.43%)